Stockreport

Data from Incyte’s Oncology Portfolio Accepted for Presentation at the 61st Annual ASH Meeting

Incyte Corporation  (INCY) 
Last incyte corporation earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: incyte.com/ir/investor-overview.aspx
PDF WILMINGTON, Del.--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) announces that numerous abstracts, including data from its clinical development programs for ruxolitinib (Jak [Read more]